Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tekni-Plex announced a $15 million investment in a new manufacturing facility in Suzhou, China.
read more
Wednesday, January 17, 2018
Charles River Laboratories announced the appointment of Jean-Paul Mangeolle, former President of AB SCIEX, to its Board of Directors.
read more
Tuesday, December 20, 2022
Kite, a Gilead Company and Tmunity Therapeutics (Tmunity), announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies...
read more
Avid Bioservices announced the appointment of Maria Ebro Andreasen as Chief People Officer.
The appointment comes as Avid continues to scale its operations to meet increasing customer demand and support long-term growth.
read more
Wednesday, March 30, 2016
Ora, Inc. has announced the addition of Simon Chandler, PhD as Senior Director to lead regulatory and clinical operations for Europe. Simon will be based in the UK.
read more
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management (RBQM) Software for clinical trials, has launched registration for RBQM Live 2023, the foremost virtual event known for shaping the future of RBQM.
read more
underwent a cGMP (Current Good Manufacturing Practices) on-site inspection by the FDA and received the EIR (Establishment Inspection Report) from the FDA. This is the fourth time that Langhua Pharmaceutical has undergone and passed the on-site ...
read more
Monday, September 13, 2021
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced the appointment of Dr. Christian Schetter, Ph.D. as Chief Scientific Officer (CSO) of Rentschler Biopharma SE, where ...
read more
Tuesday, January 10, 2023
Novotech an Asia Pacific centered biotech CRO announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group.
read more
Aphios Corporation announced has been awarded a subcontract for the nanoformulation of a super hydrophobic anticancer drug administered through the Frederick National Laboratory for Cancer Research in Frederick, MD.
read more
Monday, September 12, 2016
Alphora is pleased to announce its decision to expand plant operations with an $8M capital investment. The expansion will double the size of the plant operations, adding additional 500L, 200L and 50L vessels. The new plant is expected to be fully ...
read more
Hovione announced it has signed an agreement with Dragonfly Technologies, Inc. to gain access to its micellar technology for chemistry-in-water processes, developed by Prof. Bruce Lipshutz of the University of California, Santa Barbara (UCSB).
read more
Wednesday, March 13, 2024
LGM Pharma, a provider of API and CDMO services for the full drug product lifecycle, announced a significant enhancement of its capabilities: a 50% expansion and an investment exceeding $2 million in its standalone offering for Analytical Testing ...
read more
Thursday, August 02, 2018
LifeSciences and Particle Sciences have received a Notice of Allowance on a device for the delivery of medication to the ear-drum.
read more
Albany Molecular Research, Inc. (NASDAQ: AMRI), a leading global contract research and manufacturing organization, today announced the appointment of William S. Marth to its Board of Directors. Mr. Marth has extensive experience in leading ...
read more